These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3262333)

  • 21. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin, cortisol, and antidepressant treatment.
    Fava GA; Lisansky J; Buckman MT; Kellner R; Pathak D; Fava M; Peake GT
    Am J Psychiatry; 1988 Mar; 145(3):358-60. PubMed ID: 3344852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating cortisol & related steroids following ketoconazole challenge in Cushing's disease.
    Dash RJ; Khandekar S; Lata V; Bhansali A
    Indian J Med Res; 1990 Jun; 92():167-8. PubMed ID: 2401536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.
    Heuser IJ; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Dettling M; Yassouridis A; Holsboer F
    Am J Psychiatry; 1996 Jan; 153(1):93-9. PubMed ID: 8540599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness.
    Bodani M; Sheehan B; Philpot M
    J Psychopharmacol; 1999; 13(2):196-7. PubMed ID: 10475727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone suppression test with mildly to moderately depressed outpatients.
    Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J
    Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dexamethasone suppression test and endogenous components of evoked potentials in depressed subjects].
    Pholien P; Charles G; Tilmant JJ; Wilmotte J
    Acta Psychiatr Belg; 1987; 87():694-703. PubMed ID: 3452988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma ACTH and cortisol levels in depressed patients: relation to dexamethasone suppression test.
    Fang VS; Tricou BJ; Robertson A; Meltzer HY
    Life Sci; 1981 Aug; 29(9):931-8. PubMed ID: 6272051
    [No Abstract]   [Full Text] [Related]  

  • 31. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ketoconazole and dexamethasone suppression tests].
    Roca B; Arenas M
    An Med Interna; 1993 Mar; 10(3):151-2. PubMed ID: 8485290
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of concurrent medical illness on dexamethasone suppression test results in depressed inpatients.
    Cooke RG; Warsh JJ; Stancer HC; Hasey GM; Jorna T; Langlet F
    Can J Psychiatry; 1990 Feb; 35(1):31-5. PubMed ID: 2317731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dexamethasone suppression test during recurrent major depressive episodes.
    Yerevanian BI; Privitera MR; Milanese E; Sagi EA; Russotto JC
    Biol Psychiatry; 1984 Mar; 19(3):407-12. PubMed ID: 6722230
    [No Abstract]   [Full Text] [Related]  

  • 37. Dexamethasone suppression test and response to antidepressants in depressed outpatients.
    Peselow ED; Fieve RR
    N Engl J Med; 1982 Nov; 307(19):1216-7. PubMed ID: 7121554
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the ACTH suppression test and dexamethasone suppression test in depressed patients.
    Demisch K; Demisch L; Bochnik HJ; Schulz F
    Am J Psychiatry; 1983 Nov; 140(11):1511-2. PubMed ID: 6312817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physostigmine's influence on DST results.
    Berger M; Doerr P; von Zerssen D
    Am J Psychiatry; 1984 Mar; 141(3):469-70. PubMed ID: 6703121
    [No Abstract]   [Full Text] [Related]  

  • 40. Adrenocortical steroid secretion and 11-beta-steroid hydroxylase activity after pituitary-adrenocortical probes in depression.
    Holsboer F
    Psychiatr Med; 1985; 3(1):65-78. PubMed ID: 2885897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.